EDUCATION INNOVATION EVIDENCE

YEARS

OF LOOKING

FORWARD

First Announcement

AorticControversies

AcuteStroke

Controversies

VenousControversies

10 Years ofCX VenousWorkshop

PeripheralArterial

Controversies

Interdisciplinary Leg Initiative

10 Years of

Controversies UpdateVascular & Endovascular

24–27 APRIL 2018OLYMPIA GRAND • LONDON • UNITED KINGDOM

Years of Looking Forward

2 Vascular & Endovascular Controversies Update

Chairman

Roger Greenhalgh Emeritus Professor of Surgery and Head of Vascular

Surgery Research Group at Imperial College London, London, UK

Co-chairmen

Frans Moll Emeritus Professor of Vascular Surgery at University

Medical Center Utrecht, Utrecht, Netherlands

Stéphan Haulon Professor of Vascular Surgery, Université Paris Sud,

Hôpital Marie Lannelongue, Le Plessis Robinson, France

Andrew Holden Associate Professor of Radiology at Auckland University

School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand

Aortic

Dittmar Böckler Professor of Vascular Surgery at University of

Heidelberg and Head of Department of Vascular Surgery and Endovascular Surgery at University Hospital Heidelberg, Heidelberg, Germany

Giovanni Torsello Emeritus Professor, Department of Vascular Surgery

at Franziskus Hospital and Director of the Clinic for Vascular and Endovascular Surgery at the University of Münster, Münster, Germany

Tilo Kölbel Professor of Vascular Surgery, University of Hamburg,

and Vascular Surgeon at the University Heart Center Hamburg, Hamburg, Germany

Frank Vermassen Professor in Vascular and Thoracic Surgery Department

of Vascular Surgery at Ghent University Hospital, Ghent, Belgium

Late-Breaking Aortic Trials

Janet Powell Professor of Vascular Biology and Medicine, Imperial

College London, London, UK

We are pleased to invite you to join us once again in London, UK, for the Charing Cross International Symposium 2018, the vascular and endovascular annual meeting where education, innovation and evidence merge in one place.

For 40 years, CX has continually looked forward, raising vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle.

In 2018, the programme will focus on controversies in all aspects of vascular disease management and we will be introducing new and exciting activities, with an increase in hands-on workshops and live and edited cases. Also in 2018, the CX Venous Workshop and ilegx will be celebrating their 10th anniversaries.

At CX 2018, the programmes for the Aortic, Peripheral Arterial, Venous, Acute Stroke and Vascular Access tracks have been designed in sequence rather than in parallel so that CX attendees can maximise their participation.

We look forward to welcoming you to CX 2018!

CX Programme Organising Board

NEW for CX 2018• Peripheral Arterial live case transmissions and from

multiple centres

• CX Aortic, CX Peripheral Arterial and CX Vascular Access Villages for dedicated hands-on workshops in addition to the CX Venous Workshop (10th anniversary)

• ilegx (10th anniversary)

• High profile Late-Breaking Aortic, Peripheral Arterial and Venous Clinical Trial Sessions

• Techniques & Technologies Sessions for Aortic, Peripheral Arterial, Venous and Vascular Access

• Far more opportunities for interaction with CX Faculty and exhibitors

• CX "40 Years of Looking Forward" Thursday Party

24–27 April 2018

3

Peripheral Arterial

Cliff Shearman Professor of Vascular Surgery at University of

Southampton and Vascular Surgeon in the Department of Vascular Surgery, University Hospital Southampton Foundation Trust, Southampton, UK

Michael Edmonds Professor of Diabetic Foot Medicine and Consultant

Diabetologist at King’s College Hospital, London, UK

Thomas Zeller Professor of Angiology at Albert-Ludwigs University

of Freiburg and Head of Department of Angiology at Universitäts – Herzzentrum Freiburg, Bad Krozingen,

Germany

Giovanni Torsello Emeritus Professor, Department of Vascular Surgery

at Franziskus Hospital and Director of the Clinic for Vascular and Endovascular Surgery at the University of Münster, Münster, Germany

Iris Baumgartner Professor and Head of Clinical and Interventional

Angiology and Director of Vascular Research at University Hospital Bern, Bern, Switzerland

Trevor Cleveland Consultant Vascular Radiologist and Honorary Senior

Lecturer at Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Frank Vermassen Professor in Vascular and Thoracic Surgery Department

of Vascular Surgery at Ghent University Hospital, Ghent, Belgium

Late-Breaking Peripheral Arterial Trials

Venous

Ian Franklin Consultant Vascular Surgeon at London Vascular Clinic,

London, UK

Stephen Black Consultant Vascular Surgeon at Guy’s and St Thomas’

Hospital, London, UK

Alun Davies Professor of Vascular Surgery at Imperial College

London and Consultant General Surgeon at Charing Cross Hospital, London, UK

Late-Breaking Venous Trials

Alun Davies Professor of Vascular Surgery at Imperial College

London and Consultant General Surgeon at Charing Cross Hospital, London, UK

Congenital Vascular Malformations

Krassi Ivancev (Chairman) Consultant Interventional Radiologist, Royal Free

London, Honorary Professor, Division of Surgery & Interventional Sciences, Faculty of Medical Sciences, University College London

Iris Baumgartner Professor and Head of Clinical and Interventional

Angiology and Director of Vascular Research at University Hospital Bern, Bern, Switzerland

George Hamilton Consultant Vascular Surgeon, Royal Free NHS Hospital

and Great Ormond Street Hospital for Children, Professor, University College London, London, UK

Malcolm Simms Consultant Vascular Surgeon, Birmingham, UK

Acute Stroke

Ross Naylor Honorary Professor of Vascular Surgery at University of

Leicester and Consultant Vascular Surgeon at Leicester Royal Infirmary, Leicester, UK

Hugh Markus Professor of Stroke Medicine, Honorary Consultant

Neurologist, University of Cambridge, Cambridge, UK

Next-Generation Vascular Specialists

Rob Hinchliffe Clinical Professor of Vascular Surgery at University of

Bristol and Vascular Surgeon at North Bristol NHS Trust, Bristol, UK

Vascular Access

Nicholas Inston Consultant Surgeon and Clinical Lead for Renal Surgery

and Transplantation at Queen Elizabeth Hospital Birmingham, Birmingham, UK

Domenico Valenti Consultant Vascular Surgeon and Honorary Senior

Lecturer at King’s College London, London, UK

CX Abstract BoardIan LoftusMeryl Davis Richard Gibbs

Robert HinchliffeColin BicknellDaryll Baker

Rachel BellMarcus BrooksSimon Ashley

International AdvisorsPatrick PeetersEric Verhoeven

Gunnar TepeJan Brunkwall

Eric ChemlaMatt Thompson

Years of Looking Forward

4 Vascular & Endovascular Controversies Update

CX 2018 Preliminary Programme Highlights

• What counts in deciding to intervene in claudicants

• When to intervene for the SFA + treatment algorithm by lesion type (DCBs vs DES + stents vs PTA)

• Endovascular first vs bypass first for critical limb ischaemia

• Tibial angioplasty vs infrapopliteal bypass + plantar loop angioplasty vs plantar bypass

• Role of gene therapy and deep venous arterialisation for “no option” CLI

Late-breaking peripheral arterial and wound healing trials

Day 2: NEW Peripheral Techniques & Technologies (Live Cases)Wednesday, 25 April 2018

Day 3: ilegx – focused on saving legsThursday, 26 April 2018

NEW CX Peripheral Arterial Workshop – Peripheral Village

CX Abstracts and E-posters

3 Days of Peripheral Arterial ControversiesDay 1: Plenary Programme – Tuesday, 24 April 2018 Additional Peripheral Sessions

Abdominal Aortic Controversies

• Value of screening programmes in men with AAA

• Role of sac sealing technologies

• Conversion after EVAR / EVAS

• Impact of centralisation + EVAR on the treatment of ruptured aneurysms

• ChEVAR vs FEVAR vs CHEVAS vs ChFEVAR vs open repair in aneurysms with short necks

• Treatment of mycotic aneurysm: EVAR vs open surgery

Thoracic Aortic Controversies

• Correlation of volume and outcome for TEVAR + open surgery

• Outcomes of TEVAR for chronic type B dissection

• TEVAR treatment of ruptured descending thoracic aortic aneurysms

• Open thoracoabdominal aortic aneurysm repair after failed TEVAR

• Endovascular techniques in trauma (REBOA) and pelvic embolization

• Treatment of mycotic thoracic aortic aneurysms

Late-breaking aortic trials

3 Days of Aortic ControversiesDay 2: Plenary Programme – Wednesday, 25 April 2018 Additional Aortic Sessions

Day 1: NEW Aortic Techniques & Technologies (Edited Cases)Tuesday, 24 April 2018

NEW CX Aortic Workshop – Aortic Village

CX Abstracts and E-posters

Day 3: Plenary Programme – Thursday, 26 April 2018

24–27 April 2018

5

Carotid and Vertebral Controversies

• Debates based on the ESVS carotid/vertebral guidelines 2017/2018

Acute Stroke Controversies

• Stroke from Thoracic Endovascular Procedures (STEP) – Incidence and global collaboration for optimal results

CX Abstracts and E-posters

Acute Stroke ControversiesDay 1: Plenary Programme – Friday 27, April 2018 Additional Acute Stroke Sessions

Complex and end stage vascular access

• Upper limb complex access (basilic veins vs arteriovenous grafts)

• Lower limb access (autologous vs arteriovenous grafts vs HeRO)

• Maintaining access in central venous catheter occlusion – role of central stents

• Best treatment for total venous occlusion

Late-breaking trials in vascular access

Day 2: CX Vascular Access Workshop – Techniques & TechnologiesThursday, 26 April 2018

CX Abstracts and E-posters

2 Days of Vascular Access CourseDay 1: Plenary Programme – Wednesday, 25 April 2018 Additional Vascular Access Sessions

• Pharmacomechanical thrombolysis vs medical treatment for acute DVT

• Deep venous stenting for chronic venous diseases

• Mechanochemical ablation (MOCA) and adhesive closure

• Downsides of adhesive closure and thermal ablation

• Early vs delayed endovenous treatment of superficial venous reflux

Late-breaking trials for venous disease and CCSVI

Day 2: NEW Venous Techniques & Technologies (Edited Cases)Wednesday, 25 April 2018

Days 2 and 3: CX Venous Workshop – Venous CityWednesday, 25 April and Thursday, 26 April 2018

CX Abstracts and E-posters

3 Days of Venous ControversiesDay 1: Plenary Programme – Tuesday, 24 April 2018 Additional Venous Sessions

Years of Looking Forward

6 Vascular & Endovascular Controversies Update

Abstract submission deadline: Sunday, 22 October 2017The Charing Cross Symposium invites senior and trainee clinicians working in the vascular and endovascular field to submit an abstract to be considered for presentation at the CX Open Abstract Session or as an Electronic Poster

Best Abstract awards:The best abstract presentation in each category (senior and trainee) will be awarded £1,000 and a diploma for best presentation. The best Electronic Poster presentation will receive complimentary registration for CX 2019.

Abstracts to be presented in the CX Vascular Access Programme will be judged separately and the best presentation will be awarded £500.

Prize and Certificate of Merit winners will be invited to submit topics for the CX Plenary Programme for 2019.

Visit www.cxsymposium.com/abstracts to submit your abstract.

Call for Abstracts for CX 2018

Areas for submission include: • Peripheral Arterial

• Abdominal Aortic

• Thoracic Aortic

• Acute Stroke

• Venous

• Vascular Access

Abstract acceptance leads to: • Inclusion of abstracts in the CX Abstract Book

• Inclusion of name and title in the CX Final Programme

• Complimentary registration for CX 2018 (trainee clinicians only)

• A chance to receive a Certificate of Merit for outstanding presentation

Additional CX Course Additional CX Sessions

Additional CX Courses and Sessions

CX Congenital Vascular Malformations

CX Innovation Showcase

CX Meets Latin America

CX Meets China

24–27 April 2018

7

What has made CX so special over 40 years of looking forward?

CX 4-DAY RATE (Access all areas, including Vascular Access)

CX 1-DAY RATE(Access all areas for Tuesday, Wednesday or Thursday)

Early bird* Standard rate Late / onsite registration** Early bird* Standard rate Late / onsite

registration**

Physician (Excluding juniors, trainees, fellows, interns)

£695 £795 £895 £295 £345 £385

Junior 1

(Includes Trainees, Fellows, Interns)

£345 £395 £445 £150 £180 £195

Vascular technologist 1 / Nurse 1 £145 £175 £195 £75 £95 £105

The 4-day rate includes the symposium book The 1-day rate(s) excludes the symposium book

CX ACUTE STROKE – FRIDAY

Early bird* Standard rate Late/onsite registration**

£95 £115 £125Note: Friday only. Excludes symposium book. Bag

will be subject to availability.

Registration & AccommodationEarly Bird Registration Deadline: Sunday, 25 February 2018

* Early bird rates are valid on applications received before midnight on 25th February 2018.** Late/onsite registration applies after Friday 20th April 2018.1 This fee is subject to verification of status in the form of a letter from your head of department.

Book your accommodation close to the venue at special rates.For CX we partner with various nearby hotels to give you a selection of options at preferential rates. Please visit www.cxsymposium.com/hotels for more information.

Register at www.cxsymposium.com/registration

“CX has always been a good meeting to challenge my thinking. It has allowed me to participate in interesting

conversations and to gain—particularly with the workshops—tips and tricks for my own practice.” Stephen Black, London, UK

“ Each year I attend CX I come away with consensus messages that change or improve my practice and

that I can share with my colleagues. I look forward to next year being the same.” Andrew Holden, Auckland, New Zealand

“ At CX we discuss clinical science getting information about what is up to date with regards to new

developments and technologies in the light of what is considered as being the benchmark.” Thomas Zeller, Bad Krozingen, Germany

“ CX is optimal education! The symposium provides us with really strong evidence for what we are doing

every day, leading to appropriate decision-making for patients.” Dittmar Böckler, Heidelberg, Germany

CX SYMPOSIUM @CXSYMPOSIUM

www.cxsymposium.com

YEARS

OF LOOKING

FORWARD

KEY MILESTONES

Controversies UpdateVascular & Endovascular

24–27 APRIL 2018OLYMPIA GRAND • LONDON • UNITED KINGDOM

2011 Andres Schanzer

and Roy Green-

berg’s study on

the importance

of adhering to IFU’s for EVAR

is presented at CX as well as

published in Circulation

General enquiries Charing Cross Symposium, 526 Fulham Road, London SW6 5NR, United Kingdom

Tel: +44 (0) 20 7736 8788, Fax: +44 (0) 20 7736 8283, Email: info@cxsymposium.com

1986Andreas Grüntzig, the father

of percutaneous transluminal

angioplasty, presents at CX

1987Michael DeBakey,

inventor of the

heart pump,

takes part in CX,

leading to the

creation of ESVS

1990Julio Palmaz

presents

‘stent graft

concept’ at

CX

2010The EVAR Trials 10-Year

Results are presented at CX

and simultaneously published

in the NEJM

2015Gunnar Tepe

presents the

one-year

results from the

IN.PACT SFA

Randomised Trial